|
Diagnostic groupa
|
Cases (subgroup%)
|
Incidence rate (per 106person-years)
|
|---|
|
Leukaemia
| | |
|
Acute lymphoid leukaemia (ALL)
|
591 (45%)
|
9.7
|
|
Acute myeloid leukaemia (AML)
|
463 (36%)
|
7.6
|
|
Chronic Myeloid leukaemia (CML)
|
147 (11%)
|
2.4
|
|
Other leukaemia
|
98 (8%)
|
1.6
|
|
All leukaemias
|
1299
|
21.3
|
|
Lymphoma
| | |
|
Non-Hodgkin’s lymphoma (NHL)
|
991 (32%)
|
16.3
|
|
Hodgkin’s lymphoma (HL)
|
2079 (68%)
|
34.1
|
|
All lymphomas
|
3070
|
50.3
|
|
CNS tumours
| | |
|
Astrocytoma
|
629 (33%)
|
10.3
|
|
Other Glioma
|
195 (10%)
|
3.2
|
|
Ependymoma
|
99 (5%)
|
1.6
|
|
Medulloblastoma
|
111 (6%)
|
1.8
|
|
Other Specified CNS
|
702 (37%)
|
11.5
|
|
Unspecified CNS
|
146 (8%)
|
2.4
|
|
All CNS tumours
|
1882
|
30.9
|
|
All leukaemia, lymphoma and CNS tumours
|
6251
|
102.5
|
-
aDefined according to the Birch Teenage and Young Adult Classification Scheme [24].
-
Abbreviation:
CNS central nervous system.
